Measurement of Bladder Function Change In Patients With SVMs Before and After Surgical Intervention
Sponsor
Xuanwu Hospital, Beijing (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT03280186
Collaborator
(none)
100
1
11
Study Details
Study Description
Brief Summary
The investigators goal is to create a better understanding of patient with SVMs reported outcomes for bladder management strategies before and after surgery.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Spinal Vascular malformations (SVMs) are complex neurosurgical lesions and account for 3%-4% of all intradural spinal cord mass lesions, which can influence the function of bladder. However, no study show the relationship of the SVMs and bladder function. The investigators goal is to create a better understanding of patient reported outcomes for bladder management strategies before and after surgery.
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Measurement of Bladder Function Change In Patients With Spinal Vascular Malformations Before and After Surgical Intervention
Anticipated Study Start Date
:
Jan 1, 2022
Anticipated Primary Completion Date
:
Oct 1, 2022
Anticipated Study Completion Date
:
Dec 1, 2022
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Patients With SVMs Patients with SVMs will be included in the group and undergo surgery. |
Procedure: surgery
The minimally invasive surgical treatment methods and new techniques will be adopted such as spinal superselective angiography, preoperative embolization, intraoperative electrophysiological monitoring, intraoperative angiography, etc.
|
Outcome Measures
Primary Outcome Measures
- bladder function change in urodynamics [postoperative 3 months and 12 months]
bladder function will be better in urodynamics after surgery.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- patient diagnosed with spinal vascular diseases including intradural arteriovenous malformation, intradural arteriovenous fistula, dural arteriovenous fistula, extradural arteriovenous malformation, paravertebral arteriovenous malformation, paravertebral arteriovenous fistula, cobbs' syndrome, other spinal arteriovenous metameric syndromes involve the spinal cord. patient not received surgical or interventional treatment before patient with normal cardiac, renal and hepatic function patient capable of understanding the content of the patient information / Informed Consent Form patient willing and able to participate in the registry
Exclusion Criteria:
- patient received surgical treatment or interventional treatment before patient is pregnant patient allergic to iodine patient unable to complete follow-up patient with cerebral lesions patient with other spinal lesions patient with cardiac, renal or hepatic dysfunction
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Xuanwu Hospital, Beijing
Investigators
- Study Director: Tongwen Ou, M.D, Xuanwu Hospital, Beijing
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
ou tongwen,
Director of Urology,
Xuanwu Hospital, Beijing
ClinicalTrials.gov Identifier:
NCT03280186
Other Study ID Numbers:
- otw-20170908
First Posted:
Sep 12, 2017
Last Update Posted:
Apr 29, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by ou tongwen,
Director of Urology,
Xuanwu Hospital, Beijing
Additional relevant MeSH terms: